Company news

ORHUB, Inc. news in 2023

ORHUB, Inc.'s news releases, calls and decks from 2023, newest first.

View company

HippoFi Ships International Orders and Expects Sales to Exceed $20 Million in the New Year

December 10, 2023

HippoFi ships international orders and expects sales to exceed $20 million in the new year

December 11, 2023

HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities

December 5, 2023

HippoFi Continues to Deliver Sales Growth Adding 14 Major Healthcare Facilities

December 4, 2023

Dr. Gail Naughton, World-Renowned Authority in the Multibillion-Dollar Regenerative Medicine Market, Joins HippoFi as the Head of Regenerative Therapeutics and Commercialization

November 6, 2023

International Sales Win for PUR Biologics

October 23, 2023

International sales win for PUR biologics

October 24, 2023

PUR Biologics Secures Innovative Medical Patent with Strong Financial Upside

September 11, 2023

PUR biologics secures innovative medical patent with strong financial upside

September 12, 2023

HippoFi Announces Strategic Alliance to Lead Spinal Biologics Innovation

September 5, 2023

HippoFi announces strategic alliance to lead spinal biologics innovation

September 6, 2023

HippoFi to announce strategic alliance with orthopedic industry leader

September 1, 2023

US Patent Office Issues New Patent to PUR Biologics for Advanced Cartilage Regeneration and Arthritis Solutions

August 13, 2023

HippoFi Finalizes an Exclusive Strategic Partnership with International Biomedical Manufacturing Company, BPB Medica

August 8, 2023

HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market

July 25, 2023

HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device

July 24, 2023

HippoFi Anticipates a New Strategic Partnership as the Company Prepares to Launch PURmarrow 360, a Patented Stem Cell Harvesting Device

July 24, 2023

HippoFi's PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States

June 26, 2023

PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough(TM)

May 8, 2023

PUR Biologics Begins Shipment of its Breakthrough Product PURbonedough™

May 9, 2023

PUR Biologics Expands Sales Network by 15%, Adding 32 New Distributors

April 26, 2023

CORRECTION BY SOURCE: Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.

April 19, 2023

Goldman Small Cap Research Publishes New Research Report on HippoFi, Inc.

April 19, 2023

US Patent Office Grants PUR Biologics' Breakthrough Patent for Activating Immune Cells

April 18, 2023

US Patent Office Grants PUR Biologics’ Breakthrough Patent for Activating Immune Cells

April 19, 2023

PUR Biologics Launches PURfiberXP(TM), a Best-in-Class Cortical Fiber Matrix for Bone Regeneration

April 12, 2023

PUR Biologics Launches PURfiberXP™, a Best-in-Class Cortical Fiber Matrix for Bone Regeneration

April 12, 2023

HippoFi Announces Its Return to a Pink Current Information Tier on the OTC Market

April 10, 2023

PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery

April 5, 2023

HippoFi Begins 2023 with Strong Sales of Advanced Biomaterials

January 11, 2023